富祥药业：第三季度净利润亏损5584.04万元，下降40.96%

Core Insights - The company reported a third-quarter revenue of 255 million, representing a decline of 13.51% [1] - The net profit for the third quarter was a loss of 55.84 million, down 40.96% [1] - For the first three quarters, the total revenue was 769 million, a decrease of 21.24% [1] - The net profit for the first three quarters was a loss of 62.75 million, showing a slight decline of 1.09% [1]